Of the pediatric patients in the study, 15% had secondary AIHA related to a primary immunodeficiency. Half of these primary immunodeficiencies were common variable immunodeficiency (CVID), with ...

The data discussed earlier indicate that MMF may have value as an alternative treatment for AIH patients who do not respond to standard treatment. However, more data are required. Randomized ...

However, for many people, hair loss can be an exhausting experience, typically caused by underlying medical concerns. Among these, autoimmune diseases play a significant role. These conditions occur ...

Autoimmune disease rashes can occur when the immune system mistakenly attacks the body's cells, tissues, and organs. An autoimmune disease rash can indicate a flare-up (times of increased disease ...

Three of the 16 patients were started on MMF for reasons other than AIH. AI: Autoimmune; AIH: Autoimmune hepatitis; AST: Aspartate aminotransferase; AZA: Azathioprine; MMF: Mycophenolate mofetil ...

Immunological disorders are conditions arising from immune system dysfunction, encompassing primary immunodeficiency syndromes, inborn errors of immunity, autoimmune diseases, asthma, allergies, ...

Compelling data generated in preclinical animal models indicate that regulatory T cells can be used as therapeutic agents for inducing tolerance to alloantigens after transplantation or for re ...

Roche’s Genentech unit has tapped Cour to help develop and commercialize the biotech’s bespoke tolerogenic nanoparticle treatments for autoimmune diseases, Cour said Tuesday. Under the deal ...

EBViously, a spin-off of Helmholtz Munich, officially started operations on 11 November 2024. The company is developing a ...

Fintel reports that on December 20, 2024, Rodman & Renshaw initiated coverage of Atara Biotherapeutics (NasdaqGS:ATRA) with a ...